Overview

Digital Health can be described as the convergence between digital technologies and healthcare solutions. However, multiple questions concerning both the usage and sharing of data and the pricing and reimbursement of digital health solutions remain unanswered.
By putting in the same table Industry representatives, involved in the multiple Digital Health related disciplines, together with Regulatory Agencies and other relevant stakeholders, this Workshop aims to be a discussion platform for the currently most relevant Digital Health topics, such as the qualification procedures across the globe, Real World insight generation, Data ethics, pricing and reimbursement of Digital Health solutions, virtual and remote trials, among many others. Join us to learn more on the fast evolving Digital Healthcare ecosystem and to listen to the aspiration from various stakeholders on the future of Digital health and the value to patients, HCP, Payers and many other players in healthcare.

Featured topics

Early dialogue with regulators and qualification procedure across the globe
Patient centricity as the key – the link between the biology of the disease and Digital Health solutions
Real World insight generation
Technology:
- Mobile health
- Sensors and endpoints
- Artificial Intelligence and Machine learning
Aspirations towards the future of Digital Health
Data ethics: access, usage, and sharing of data
Pricing and reimbursement of Digital Health solutions
Decentralized, virtual and Remote trials

Who should attend?

Professionals involved in:

Digital health
Digital solutions
Data Management
R&D
Innovation
Artificial Intelligence and Machine Learning
Clinical operations and Clinical development
Market Access & Reimbursement
Bioethics
Real World Evidence
Regulatory Innovation
Patient Advocacy

Learning objectives

Recognise the current challenges and opportunities in Digital Health, both scientifically, in terms of value proposition and credibility of Data
Discuss what is Digital Ethics and how to use it
Understand the current regulatory thinking regarding new technologies

Program Committee

Katarzyna Kolasa, PhD Professor of Health Economics, Head of Dept. of Health Economics and Health Mgmt
Kozminski University, Poland
Maria Raad Vice President, Customer and Digital Strategy
Janssen EMEA Commercial, Switzerland
Michael Forstner, PhD, MPH, MSc Managing Director, Head of Pharmacoepidemiology Practice
Mesa Laubela-Consulting, Switzerland
Scott Askin, MSc Global Program Regulatory Director
Novartis Pharma AG, Switzerland

Digital Learning Catalog

Download

Have an account?

Register

Digital Health Workshop